Ilika plc signs MOU with Cirtec Medical

Ilika plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has announced it has broadened its relationship with Cirtec Medical, an industry-leading strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, by signing a memorandum of understanding which outlines the transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility in Lowell, Massachusetts, U.S.

Ilika will focus on advanced technology development and IP licensing in support of Cirtec’s manufacturing and commercialisation activities. This partnership will reinforce Cirtec’s ongoing activities in system level miniaturisation for the medical device industry. Benefits of this partnership, to Ilika, include:

·    Further validation of Stereax’s capabilities

·    Manufacturing partnership delivering economy of scale and ability to rapidly ramp production

·    Expanded business development team bringing additional commercial momentum

In due course Ilika and Cirtec envisage signing a contract once the terms of the partnership have been finalised and a further announcement will be made at this time.

Graeme Purdy, Ilika Plc’s Chief Executive Officer, said: “Our partnership with Cirtec reinforces a pathway towards commercialisation of our Stereax battery technology. Cirtec brings a wealth of manufacturing experience and a strong track record of successful product commercialisation in the medical device industry.”

Brian Highley, Cirtec Medical Chief Executive Officer, commented: “With over 20 years of experience in the design, development and manufacturing of medical devices, Cirtec is uniquely poised to work with Ilika in bringing its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets.”

Ilika specializes in the development of solid-state batteries. Its Stereax product line is designed for miniature medical implants and specialist internet of Things (IoT) applications. Stereax enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs. 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Ilika announces £3.5m fundraise via Placing and Retail Offer

Ilika Plc, a leader in solid-state battery technology, plans to raise approximately £3.0 million through a new share placing and a retail offer for shareholders.

Ilika’s Goliath prototypes win OEM validation

Ilika plc has confirmed its P1 Goliath solid-state battery prototypes meet specifications, showcasing significant progress in testing and commercial viability.

Ilika completes Goliath scale-up with UKBIC

Ilika plc confirms the success of its Goliath solid-state batteries, showcasing superior performance and scalability in production for electric vehicles.

Ilika successfully prototypes 50Ah Goliath EV battery

Ilika plc has successfully prototyped a 50Ah solid-state battery for electric vehicles, marking a significant step toward commercialisation and enhanced EV performance.

Ilika’s Goliath achieves manufacturing scale-up with UKBIC collaboration

Ilika plc (LON:IKA) advances its Goliath solid-state battery commercialization through successful UK Battery Industrialisation Centre collaboration.

Ilika plc Advancing Solid-State Battery Innovation with Strategic Milestones

Ilika plc reports impressive 2024 half-year results, advancing solid-state battery tech with Stereax and Goliath for MedTech and EV applications.

Search

Search